A New Standard for Precision Chemistry
Cambridge Isotope Laboratories, Inc. (CIL), a global leader in stable-isotope chemistry, has unveiled ISOAPI-D™, a new line of deuterated reagents purpose-built for pharmaceutical R&D and active pharmaceutical ingredient (API) synthesis.
The launch took place at CPhI Frankfurt 2025 (October 28–30), marking a significant milestone in the evolution of isotope-labeled chemistry and setting a new benchmark for reagent purity and consistency.
What Makes ISOAPI-D™ Different
CIL’s ISOAPI-D™ portfolio offers high-quality, isotopically labeled intermediates designed to accelerate drug development by simplifying synthetic routes and reducing production steps.
Each reagent is produced under ISO 9001–certified quality systems, ensuring full traceability, purity, and lot-to-lot consistency.
Key Highlights
-
🧪 High-purity deuterated intermediates for pharmaceutical synthesis and metabolic studies
-
🌍 Global manufacturing network across North America, Europe, and Asia — ensuring a secure, diversified supply chain
-
♻️ Sustainability and reliability using tritium-free heavy water (D₂O) from approved partners and environmentally responsible recovery processes
-
⚗️ Efficiency and innovation designed to streamline synthetic pathways, reduce costs, and accelerate time-to-market for new drug molecules
Why Deuterated Reagents Matter
Deuterated compounds are increasingly valuable in modern drug discovery and pharmaceutical manufacturing. They help:
-
Improve metabolic stability
-
Enhance pharmacokinetic profiles
-
Support ADME studies (absorption, distribution, metabolism, excretion)
-
Strengthen isotope-dilution assays and analytical workflows
With ISOAPI-D™, CIL brings decades of isotope expertise to help scientists create safer, longer-lasting, and more efficient therapies — supported by a reliable reagent supply chain and documentation suitable for regulatory compliance.
CIL’s Legacy of Quality and Innovation
Since 1981, Cambridge Isotope Laboratories has been recognized globally for producing high-purity stable isotope-labeled materials, including solvents, reference standards, and chemical intermediates.
The introduction of ISOAPI-D™ strengthens CIL’s position as a trusted partner for pharmaceutical, analytical, and research laboratories — blending scientific precision with robust logistics and compliance assurance.
What This Means for Laboratories and Distributors
For laboratories involved in QC testing, R&D, and regulated manufacturing, ISOAPI-D™ offers next-generation reagents built for precision, reproducibility, and reliability.
For distributors like us, this launch highlights the growing need to deliver premium-grade isotopic reagents that meet strict quality standards and global supply-chain demands.
By partnering with suppliers such as Cambridge Isotope Laboratories, we ensure clients gain access to the most advanced reagent technologies — helping them stay ahead in innovation, compliance, and performance.
Explore ISOAPI-D™ with Us
If your laboratory is developing new pharmaceutical compounds or requires certified, high-purity deuterated reagents for analytical or R&D workflows, our team is ready to assist.
We are proud to support CIL’s ISOAPI-D™ portfolio and other premium isotopic reagents designed to advance research, quality control, and pharmaceutical manufacturing.
